Trial Profile
Phase II trial of MGL-3196 in patients with elevated cholesterol and triglycerides
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2013
Price :
$35
*
At a glance
- Drugs Resmetirom (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- 17 Apr 2013 New trial record